Free Trial

Accenture (ACN) Competitors

Accenture logo
$178.69 -7.53 (-4.04%)
As of 01:22 PM Eastern

ACN vs. CAR, CCRN, CRAI, CTSH, and NVDA

Should you buy Accenture stock or one of its competitors? MarketBeat compares Accenture with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Accenture include Avis Budget Group (CAR), Cross Country Healthcare (CCRN), Charles River Associates (CRAI), Cognizant Technology Solutions (CTSH), and NVIDIA (NVDA).

How does Accenture compare to Avis Budget Group?

Accenture (NYSE:ACN) and Avis Budget Group (NASDAQ:CAR) are related companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, valuation, risk, earnings, media sentiment and dividends.

Accenture has higher revenue and earnings than Avis Budget Group. Avis Budget Group is trading at a lower price-to-earnings ratio than Accenture, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Accenture$69.67B1.71$7.68B$12.2114.65
Avis Budget Group$11.65B0.53-$889M-$19.05N/A

Accenture has a net margin of 10.61% compared to Avis Budget Group's net margin of -5.68%. Accenture's return on equity of 26.33% beat Avis Budget Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Accenture10.61% 26.33% 12.94%
Avis Budget Group -5.68%N/A -0.47%

In the previous week, Accenture had 29 more articles in the media than Avis Budget Group. MarketBeat recorded 41 mentions for Accenture and 12 mentions for Avis Budget Group. Accenture's average media sentiment score of 0.97 beat Avis Budget Group's score of 0.62 indicating that Accenture is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Accenture
27 Very Positive mention(s)
3 Positive mention(s)
7 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Avis Budget Group
4 Very Positive mention(s)
0 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Positive

Accenture has a beta of 1.08, indicating that its stock price is 8% more volatile than the broader market. Comparatively, Avis Budget Group has a beta of 1.87, indicating that its stock price is 87% more volatile than the broader market.

Accenture presently has a consensus price target of $266.58, indicating a potential upside of 49.08%. Avis Budget Group has a consensus price target of $125.25, indicating a potential downside of 28.58%. Given Accenture's stronger consensus rating and higher possible upside, analysts clearly believe Accenture is more favorable than Avis Budget Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Accenture
0 Sell rating(s)
11 Hold rating(s)
16 Buy rating(s)
0 Strong Buy rating(s)
2.59
Avis Budget Group
5 Sell rating(s)
5 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50

75.1% of Accenture shares are held by institutional investors. Comparatively, 96.4% of Avis Budget Group shares are held by institutional investors. 0.0% of Accenture shares are held by company insiders. Comparatively, 50.5% of Avis Budget Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

Accenture beats Avis Budget Group on 13 of the 16 factors compared between the two stocks.

How does Accenture compare to Cross Country Healthcare?

Accenture (NYSE:ACN) and Cross Country Healthcare (NASDAQ:CCRN) are related companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, earnings, profitability, dividends, risk, institutional ownership, media sentiment and analyst recommendations.

Accenture has a beta of 1.08, indicating that its share price is 8% more volatile than the broader market. Comparatively, Cross Country Healthcare has a beta of 0.45, indicating that its share price is 55% less volatile than the broader market.

Accenture has a net margin of 10.61% compared to Cross Country Healthcare's net margin of -9.84%. Accenture's return on equity of 26.33% beat Cross Country Healthcare's return on equity.

Company Net Margins Return on Equity Return on Assets
Accenture10.61% 26.33% 12.94%
Cross Country Healthcare -9.84%-0.74%-0.54%

Accenture has higher revenue and earnings than Cross Country Healthcare. Cross Country Healthcare is trading at a lower price-to-earnings ratio than Accenture, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Accenture$69.67B1.71$7.68B$12.2114.65
Cross Country Healthcare$1.00B0.42-$94.85M-$3.05N/A

Accenture presently has a consensus price target of $266.58, indicating a potential upside of 49.08%. Cross Country Healthcare has a consensus price target of $12.72, indicating a potential downside of 3.12%. Given Accenture's stronger consensus rating and higher probable upside, analysts clearly believe Accenture is more favorable than Cross Country Healthcare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Accenture
0 Sell rating(s)
11 Hold rating(s)
16 Buy rating(s)
0 Strong Buy rating(s)
2.59
Cross Country Healthcare
1 Sell rating(s)
9 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.90

In the previous week, Accenture had 40 more articles in the media than Cross Country Healthcare. MarketBeat recorded 41 mentions for Accenture and 1 mentions for Cross Country Healthcare. Accenture's average media sentiment score of 0.97 beat Cross Country Healthcare's score of 0.94 indicating that Accenture is being referred to more favorably in the media.

Company Overall Sentiment
Accenture Positive
Cross Country Healthcare Positive

75.1% of Accenture shares are owned by institutional investors. Comparatively, 96.0% of Cross Country Healthcare shares are owned by institutional investors. 0.0% of Accenture shares are owned by company insiders. Comparatively, 6.3% of Cross Country Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Accenture beats Cross Country Healthcare on 14 of the 16 factors compared between the two stocks.

How does Accenture compare to Charles River Associates?

Accenture (NYSE:ACN) and Charles River Associates (NASDAQ:CRAI) are related companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, risk, profitability, earnings, analyst recommendations, media sentiment, institutional ownership and valuation.

In the previous week, Accenture had 24 more articles in the media than Charles River Associates. MarketBeat recorded 41 mentions for Accenture and 17 mentions for Charles River Associates. Accenture's average media sentiment score of 0.97 beat Charles River Associates' score of 0.72 indicating that Accenture is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Accenture
27 Very Positive mention(s)
3 Positive mention(s)
7 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Charles River Associates
2 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Accenture pays an annual dividend of $6.52 per share and has a dividend yield of 3.6%. Charles River Associates pays an annual dividend of $2.28 per share and has a dividend yield of 1.7%. Accenture pays out 53.4% of its earnings in the form of a dividend. Charles River Associates pays out 31.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Accenture has raised its dividend for 20 consecutive years and Charles River Associates has raised its dividend for 7 consecutive years. Accenture is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Accenture has higher revenue and earnings than Charles River Associates. Accenture is trading at a lower price-to-earnings ratio than Charles River Associates, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Accenture$69.67B1.71$7.68B$12.2114.65
Charles River Associates$751.58M1.18$54.78M$7.2019.06

Accenture has a beta of 1.08, indicating that its stock price is 8% more volatile than the broader market. Comparatively, Charles River Associates has a beta of 0.69, indicating that its stock price is 31% less volatile than the broader market.

Accenture has a net margin of 10.61% compared to Charles River Associates' net margin of 6.22%. Accenture's return on equity of 26.33% beat Charles River Associates' return on equity.

Company Net Margins Return on Equity Return on Assets
Accenture10.61% 26.33% 12.94%
Charles River Associates 6.22%26.02%8.35%

Accenture presently has a consensus target price of $266.58, indicating a potential upside of 49.08%. Charles River Associates has a consensus target price of $245.00, indicating a potential upside of 78.51%. Given Charles River Associates' higher possible upside, analysts plainly believe Charles River Associates is more favorable than Accenture.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Accenture
0 Sell rating(s)
11 Hold rating(s)
16 Buy rating(s)
0 Strong Buy rating(s)
2.59
Charles River Associates
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50

75.1% of Accenture shares are held by institutional investors. Comparatively, 84.1% of Charles River Associates shares are held by institutional investors. 0.0% of Accenture shares are held by insiders. Comparatively, 4.5% of Charles River Associates shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

Accenture beats Charles River Associates on 14 of the 19 factors compared between the two stocks.

How does Accenture compare to Cognizant Technology Solutions?

Cognizant Technology Solutions (NASDAQ:CTSH) and Accenture (NYSE:ACN) are both large-cap computer and technology companies, but which is the better stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, media sentiment, analyst recommendations, profitability, risk, dividends and earnings.

Accenture has higher revenue and earnings than Cognizant Technology Solutions. Cognizant Technology Solutions is trading at a lower price-to-earnings ratio than Accenture, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cognizant Technology Solutions$21.11B1.20$2.23B$4.6011.60
Accenture$69.67B1.71$7.68B$12.2114.65

Cognizant Technology Solutions presently has a consensus price target of $72.68, indicating a potential upside of 36.26%. Accenture has a consensus price target of $266.58, indicating a potential upside of 49.08%. Given Accenture's stronger consensus rating and higher probable upside, analysts clearly believe Accenture is more favorable than Cognizant Technology Solutions.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cognizant Technology Solutions
0 Sell rating(s)
13 Hold rating(s)
10 Buy rating(s)
0 Strong Buy rating(s)
2.43
Accenture
0 Sell rating(s)
11 Hold rating(s)
16 Buy rating(s)
0 Strong Buy rating(s)
2.59

Cognizant Technology Solutions pays an annual dividend of $1.32 per share and has a dividend yield of 2.5%. Accenture pays an annual dividend of $6.52 per share and has a dividend yield of 3.6%. Cognizant Technology Solutions pays out 28.7% of its earnings in the form of a dividend. Accenture pays out 53.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Cognizant Technology Solutions has raised its dividend for 6 consecutive years and Accenture has raised its dividend for 20 consecutive years. Accenture is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

In the previous week, Accenture had 12 more articles in the media than Cognizant Technology Solutions. MarketBeat recorded 41 mentions for Accenture and 29 mentions for Cognizant Technology Solutions. Cognizant Technology Solutions' average media sentiment score of 1.05 beat Accenture's score of 0.97 indicating that Cognizant Technology Solutions is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cognizant Technology Solutions
14 Very Positive mention(s)
3 Positive mention(s)
9 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Positive
Accenture
27 Very Positive mention(s)
3 Positive mention(s)
7 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Cognizant Technology Solutions has a beta of 0.81, meaning that its stock price is 19% less volatile than the broader market. Comparatively, Accenture has a beta of 1.08, meaning that its stock price is 8% more volatile than the broader market.

Accenture has a net margin of 10.61% compared to Cognizant Technology Solutions' net margin of 10.41%. Accenture's return on equity of 26.33% beat Cognizant Technology Solutions' return on equity.

Company Net Margins Return on Equity Return on Assets
Cognizant Technology Solutions10.41% 17.50% 12.94%
Accenture 10.61%26.33%12.94%

92.4% of Cognizant Technology Solutions shares are owned by institutional investors. Comparatively, 75.1% of Accenture shares are owned by institutional investors. 0.4% of Cognizant Technology Solutions shares are owned by company insiders. Comparatively, 0.0% of Accenture shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Accenture beats Cognizant Technology Solutions on 14 of the 18 factors compared between the two stocks.

How does Accenture compare to NVIDIA?

Accenture (NYSE:ACN) and NVIDIA (NASDAQ:NVDA) are both large-cap computer and technology companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, analyst recommendations, earnings, media sentiment, risk, institutional ownership, valuation and profitability.

Accenture has a beta of 1.08, suggesting that its share price is 8% more volatile than the broader market. Comparatively, NVIDIA has a beta of 2.22, suggesting that its share price is 122% more volatile than the broader market.

In the previous week, NVIDIA had 410 more articles in the media than Accenture. MarketBeat recorded 451 mentions for NVIDIA and 41 mentions for Accenture. Accenture's average media sentiment score of 0.97 beat NVIDIA's score of 0.87 indicating that Accenture is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Accenture
27 Very Positive mention(s)
3 Positive mention(s)
7 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
NVIDIA
280 Very Positive mention(s)
44 Positive mention(s)
79 Neutral mention(s)
28 Negative mention(s)
16 Very Negative mention(s)
Positive

Accenture presently has a consensus price target of $266.58, indicating a potential upside of 49.08%. NVIDIA has a consensus price target of $305.38, indicating a potential upside of 41.44%. Given Accenture's higher possible upside, equities research analysts clearly believe Accenture is more favorable than NVIDIA.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Accenture
0 Sell rating(s)
11 Hold rating(s)
16 Buy rating(s)
0 Strong Buy rating(s)
2.59
NVIDIA
0 Sell rating(s)
3 Hold rating(s)
47 Buy rating(s)
3 Strong Buy rating(s)
3.00

Accenture pays an annual dividend of $6.52 per share and has a dividend yield of 3.6%. NVIDIA pays an annual dividend of $0.04 per share and has a dividend yield of 0.0%. Accenture pays out 53.4% of its earnings in the form of a dividend. NVIDIA pays out 0.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Accenture has increased its dividend for 20 consecutive years and NVIDIA has increased its dividend for 1 consecutive years. Accenture is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

NVIDIA has higher revenue and earnings than Accenture. Accenture is trading at a lower price-to-earnings ratio than NVIDIA, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Accenture$69.67B1.71$7.68B$12.2114.65
NVIDIA$215.94B24.20$120.07B$6.5333.06

75.1% of Accenture shares are owned by institutional investors. Comparatively, 65.3% of NVIDIA shares are owned by institutional investors. 0.0% of Accenture shares are owned by company insiders. Comparatively, 3.9% of NVIDIA shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

NVIDIA has a net margin of 62.97% compared to Accenture's net margin of 10.61%. NVIDIA's return on equity of 96.94% beat Accenture's return on equity.

Company Net Margins Return on Equity Return on Assets
Accenture10.61% 26.33% 12.94%
NVIDIA 62.97%96.94%72.16%

Summary

NVIDIA beats Accenture on 14 of the 20 factors compared between the two stocks.

Get Accenture News Delivered to You Automatically

Sign up to receive the latest news and ratings for ACN and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ACN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ACN vs. The Competition

MetricAccentureIT Services IndustryComputer SectorNYSE Exchange
Market Cap$118.99B$13.61B$40.50B$23.11B
Dividend Yield3.32%2.19%3.10%4.09%
P/E Ratio14.6549.35173.0431.03
Price / Sales1.719.75624.9514.71
Price / Cash12.0328.6551.7724.78
Price / Book3.653.6510.094.68
Net Income$7.68B$537.84M$1.07B$1.07B
7 Day Performance1.20%5.88%3.76%-0.50%
1 Month Performance-0.63%6.67%10.86%0.39%
1 Year Performance-42.86%-16.75%169.97%25.64%

Accenture Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ACN
Accenture
4.9269 of 5 stars
$178.82
-4.0%
$266.58
+49.1%
-40.8%$118.99B$69.67B14.65779,000
CAR
Avis Budget Group
1.8978 of 5 stars
$167.05
flat
$125.25
-25.0%
+44.2%$5.90B$11.65BN/A25,000
CCRN
Cross Country Healthcare
2.5735 of 5 stars
$13.05
flat
$12.72
-2.5%
-0.5%$421.95M$1.00BN/A6,784
CRAI
Charles River Associates
4.7527 of 5 stars
$148.23
flat
$245.00
+65.3%
-24.5%$957.57M$751.58M20.59940
CTSH
Cognizant Technology Solutions
4.7754 of 5 stars
$52.75
flat
$73.00
+38.4%
-31.3%$25.00B$21.11B11.47351,600

Related Companies and Tools


This page (NYSE:ACN) was last updated on 6/3/2026 by MarketBeat.com Staff.
From Our Partners